Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
08/2012
08/14/2012CA2514971C Regeneration and neogenesis of retinal photoreceptor cell using otx2 gene
08/14/2012CA2489212C Marker for stem cells and its use
08/14/2012CA2486345C Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species
08/14/2012CA2457485C Combination motif immune stimulatory oligonucleotides with improved activity
08/14/2012CA2429954C Method for altering cell fate
08/14/2012CA2408826C A method for generating hypermutable organisms
08/14/2012CA2404679C Adenine binding g-protein coupled receptors
08/14/2012CA2351396C Bioengineered tissue constructs and methods for producing and using them
08/14/2012CA2283476C Men1, the gene associated with multiple endocrine neoplasia type 1, menin polypeptides, and uses thereof
08/14/2012CA2251544C Cystatin b mutants
08/12/2012CA2742342A1 Msh3 expression status determines the responsiveness of cancer cells to the chemotherapeutic treatment with parp inhibitors and platinum drugs
08/09/2012WO2012106718A2 Methods of using gene expression signatures to select a method of treatment, predict prognosis, survival, and/or predict response to treatment
08/09/2012WO2012106711A2 A method for detecting chromosome structure and gene expression simultaneously in single cells
08/09/2012WO2012106674A2 Using a cytokine signature to diagnose disease or infection
08/09/2012WO2012106658A1 Methods and compositions for highly specific capture and release of biological materials
08/09/2012WO2012106632A1 Biomarkers for determining an allograft tolerant phenotype
08/09/2012WO2012106559A1 Biomarkers and methods of use thereof
08/09/2012WO2012106536A2 Systems, tip assemblies, methods and kits for introducing material into cells
08/09/2012WO2012106529A1 Jagged1 as a marker and therapeutic target for breast cancer bone metastasis
08/09/2012WO2012106525A2 Digital sequence analysis of dna methylation
08/09/2012WO2012106432A2 A genomic approach to the identification of biomarkers for antibiotic resistance and susceptibility in clinical isolates of bacterial pathogens
08/09/2012WO2012106407A2 Diagnostic and therapeutic methods and products related to anxiety disorders
08/09/2012WO2012106385A2 Methods of identifying multiple epitopes in cells
08/09/2012WO2012106384A2 Nano/microscale vehicles for capture and isolation of target biomolecules and living organisms
08/09/2012WO2012106333A1 Methods for enriching microparticles or nucleic acids using binding molecules
08/09/2012WO2012106288A2 Methods of nucleic acid quantification and detection using anomalous migration
08/09/2012WO2012106267A1 Method for discovering pharmacogenomic biomarkers
08/09/2012WO2012106244A2 Reduced artifact denaturing capillary electrophoresis of nucleic acids
08/09/2012WO2012106175A1 Trrap and grin2a mutations and use thereof for the diagnosis and treatment of melanoma
08/09/2012WO2012106089A2 3d cell viability assay
08/09/2012WO2012106081A2 Methods for reducing nucleic acid damage
08/09/2012WO2012106072A2 Methods for minimizing sequence specific bias
08/09/2012WO2012105826A1 Use of micrornas in diagnosis and therapy of aging
08/09/2012WO2012105712A1 Automatic response/light measurement device and method therefor
08/09/2012WO2012105630A1 Method for testing diseases associated with lipid metabolism, and method for assessment of prophylactic and/or therapeutic agent for diseases associated with lipid metabolism
08/09/2012WO2012105590A1 Determination marker for non-alcoholic steatohepatitis, and method for diagnosing non-alcoholic steatohepatitis using the marker as measure
08/09/2012WO2012105505A1 Highly functional liver cells derived from pluripotent stem cells, method for producing same, and method for testing metabolism/toxicity of drug
08/09/2012WO2012105176A1 Nucleic acid test device
08/09/2012WO2012104851A1 Methods of diagnosing disease using overlap extension pcr
08/09/2012WO2012104817A1 Method for genotyping
08/09/2012WO2012104642A1 Method for predicting risk of developing cancer
08/09/2012WO2012104615A1 Assay for arginyl hydroxylase activity
08/09/2012WO2012104544A1 Culture medium for microorganisms including para-aminobenzoic acid as a selective agent
08/09/2012WO2012104475A1 Method and apparatus for collecting representative microbiological water and liquid samples
08/09/2012WO2012104468A1 Method and equipment for the automated testing of microbiological samples
08/09/2012WO2012104399A2 Device and method for the generation of molecular microarrays
08/09/2012WO2012104386A1 Antagonists of grasp55 for use as a medicament
08/09/2012WO2012104360A1 Rt-pcr test for the detection of avian hepatitis e virus
08/09/2012WO2012104340A2 Markers of melanoma and uses thereof
08/09/2012WO2012104261A1 Exonuclease enabled proximity extension assays
08/09/2012WO2012104210A1 Method for determining cancer prognosis
08/09/2012WO2012103780A1 Method for determining concentration of hmg-coa reductase inhibitors
08/09/2012WO2012103637A1 Functional foods and beverages with synergistic properties to promote homeostasis
08/09/2012WO2012103594A1 Barley with modified ssiii
08/09/2012WO2012083969A3 Microrna for diagnosis of pancreatic cancer
08/09/2012WO2012075150A3 Prediction of spontaneous preterm birth by measuring cell free nucleic acids in maternal blood
08/09/2012WO2012068107A3 Autoantibody to rna-protein complex detected by quantitative pcr
08/09/2012WO2012061726A3 Compositions and methods for sequencing dna
08/09/2012WO2012060595A3 Structure with nanopore and apparatus for determining sequences of nucleic acids including the same
08/09/2012WO2012058689A3 Methods, kits and arrays for screening for, predicting and identifying donors for hematopoietic cell transplantation, and predicting risk of hematopoietic cell transplant (hct) to induce graft vs. host disease (gvhd)
08/09/2012WO2012058638A9 Nucleic acid nanostructure barcode probes
08/09/2012WO2012053850A3 Detection of target nucleic acid sequences using dual-labeled immobilized probes on solid phase
08/09/2012WO2012051210A3 Mesenchymal stem cells and related therapies
08/09/2012WO2012047015A9 Multiplex microfluidic device for selecting nucleic acid aptamers, and high throughput selection method for nucleic acid aptamers using same
08/09/2012WO2012042516A3 Prognostic methods, compositions and kits for prediction of acute lymphoblastic leukemia (all) relapse
08/09/2012WO2012040493A3 A lateral flow microfluidic assaying device and related method
08/09/2012WO2012021054A3 A diagnostic system for malaria
08/09/2012WO2012018638A3 Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures
08/09/2012WO2012012689A3 Circulating micrornas are biomarkers of various diseases
08/09/2012WO2012009567A3 Biomarkers for diagnosis of stroke and its causes
08/09/2012US20120204293 Glyphosate tolerant alfalfa events and methods for detection thereof
08/09/2012US20120204286 Ho/ll canola with resistance to clubroot disease
08/09/2012US20120204284 Tomato fruit having increased firmness
08/09/2012US20120204279 Polynucleotide derived from novel hepatitis c virus strain and use thereof
08/09/2012US20120204276 Methods related to a mutation in complement factor h-related protein 5 in patients with glomerulonephritis
08/09/2012US20120204273 Compositions relating to a phosphoprotein and methods of use
08/09/2012US20120202883 Effects of idh1 and idh2 mutations on the cellular metabolome
08/09/2012US20120202874 Antisense oligonucleotide modulation of stat3 expression
08/09/2012US20120202872 Methods and compositions for the diagnosis and prognosis of cervical intraepithelial neoplasia and cervical cancer
08/09/2012US20120202861 Novel estrogen receptor ligands
08/09/2012US20120202846 Molecular target of neurotoxicity
08/09/2012US20120202843 H3K27me3 and Cancer
08/09/2012US20120202758 Core 2glcnac-t inhibitors
08/09/2012US20120202754 Enhanced substrates for the protease activity of serotype a botulinum neurotoxin
08/09/2012US20120202751 Methods of monitoring endoplasmic reticulum (er) stress response
08/09/2012US20120202749 Secreted frizzled related protein, sfrp, fragments and methods of use thereof
08/09/2012US20120202714 Conjugate probes and optical detection of analytes
08/09/2012US20120202710 Methods and compositions for generation of germline human antibody genes
08/09/2012US20120202708 Complement factor h copy number variants found in the rca locus
08/09/2012US20120202707 Cell lines useful for assessing modulation of autophagy
08/09/2012US20120202706 6-0-sulfated polysaccharides and methods of preparation thereof
08/09/2012US20120202705 Acute kidney injury risk testing
08/09/2012US20120202700 Sample preparation and detection method
08/09/2012US20120202273 Enzymatic Conversion Of Blood Group A, B, And AB Red Blood Cells Using Alpha-N-Acetylgalactosaminidases and Alpha-Galactosidases With Unique Substrate Specificities And Kinetic Properties
08/09/2012US20120202243 IN Vivo Incorporation of Unnatural Amino Acids
08/09/2012US20120202238 Determining conditions in centrifuged blood using measured pressure
08/09/2012US20120202235 Novel fructosyl peptidyl oxidase
08/09/2012US20120202234 Methods and composition for isoprenoid diphosphate synthesis
08/09/2012US20120202233 Methods and uses of KSR kinase, and mutations thereof
08/09/2012US20120202232 Heparin-insensitive Method for Determining Direct Coagulation Factor Inhibitors